Français

Symposium on Access to Cell and Gene Therapies
Hosted by Advancing Cell and Gene Therapy in partnership with Life Sciences Ontario

Join us for an engaging and solutions-focused event bringing together key voices from across the healthcare ecosystem—including patient advocates, clinicians, researchers, hospital administrators, industry leaders, and government representatives—to tackle one of the most pressing issues in Canadian healthcare: ensuring equitable access to cell and gene therapies.

The Symposium on Access to Cell and Gene Therapies will be an interactive forum designed to generate actionable recommendations that help realize the full potential of these transformative treatments for all Canadians. As a leader committed to improving healthcare outcomes, your voice and insights are invaluable to this conversation.

Agenda

8:30 – 9:00 AM: Registration & Networking Breakfast
Doors open at 8:30am. Participants are invited to register, connect with colleagues, and enjoy light refreshments.

9:00 – 9:05 AM: Opening Remarks
Welcome from event co-hosts Advancing Cell and Gene Therapy and Life Sciences Ontario.

9:05 – 9:10 AM: Introductory Remarks
Delivered by MPP Tyler Allsopp.

9:10 – 9:25 AM: Keynote Address
Cate Murray, Stem Cell Network.

9:25 – 10:15 AM: Panel Discussion: Access to Cell & Gene Therapies
Moderator: Alison Symington, Life Sciences Ontario
Panelists:

  • Rob Annan, Genome Canada
  • Dr. Stephanie Michaud, BioCanRx
  • Kim Hanson, Breakthrough TID (formerly JDRF) 

Discussion will explore opportunities, barriers, and solutions to ensure equitable access to cell and gene therapies in Canada.

10:15 – 10:30 AM: Break & Networking

10:30 – 11:30 AM: Interactive Workshop
Participants will take part in facilitated table discussions exploring the future of CGTs, barriers to access, and pathways to solutions.

11:30 – 11:50 AM: Report Back
Each table will share key insights from the workshop with the full group.

11:50 AM – 12:00 PM: Closing Remarks & Next Steps
Summary of discussion, closing reflections, and participant evaluation.

 

About Advancing Cell & Gene Therapy

Established in 2022, Advancing Cell & Gene Therapy is a coalition of leading pharmaceutical innovators—including Alexion, Johnson & Johnson Innovative Medicines, Novo Nordisk, Ultragenyx, Vertex Pharmaceuticals, Pfizer, and Ferring Pharmaceuticals—working collaboratively to advance equitable access to life-changing and lifesaving therapies across Canada.

We invite you to be part of shaping the future of healthcare innovation.

For questions on the program, please reach out to Sarah Kabani at Sarah.Kabani@bursonglobal.com.

Advancing Cell and Gene Therapy Symposium

  • Thursday Oct 30 2025, 8:30 AM - 12:00 PM
  • MaRS Discovery District, Main Auditorium
    101 College Street
    Toronto, Ontario
    Canada
    M5G 0A3